Related Experiment Video
Updated: Jul 4, 2026
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Viral infections in paediatric patients receiving conventional cancer chemotherapy
A Simon1, O Schildgen, F Schuster
1Pediatric Hematology and Oncology, Children's Hospital Medical Centre, University of Bonn, Bonn, Germany. asimon@ukb.uni-bonn.de
Insights
Diagnosing viral infections in immunocompromised patients, especially children with cancer, uses PCR/RT-PCR. Early detection and management are crucial for preventing severe disease and controlling transmission.
Area of Science:
- Medical Virology
- Pediatric Oncology
- Immunocompromised Host Research
Background:
- Severely immunocompromised patients, particularly pediatric cancer patients, are at high risk for life-threatening viral infections.
- Viral infections in this population often stem from endogenous reactivation of latent viruses or nosocomial transmission.
- Effective diagnosis and management are critical due to prolonged viral shedding and potential for severe outcomes.
Purpose of the Study:
- To highlight the importance of modern diagnostic methods for viral infections in immunocompromised children.
- To emphasize the need for strategies to prevent and control viral transmission in healthcare settings.
- To inform healthcare providers about potential early treatment options for better patient outcomes.
Main Methods:
- Diagnosis relies on Polymerase Chain Reaction (PCR) and Reverse Transcription Polymerase Chain Reaction (RT-PCR).
- Epidemiological data and clinical spectrum of viral pathogens are continuously monitored.
- Clinical observation and awareness of potential treatment options guide management.
Main Results:
- PCR/RT-PCR based methods enable timely diagnosis of viral infections.
- Understanding viral epidemiology and clinical presentations aids in managing this susceptible population.
- Viral infections can lead to severe, life-threatening conditions in pediatric cancer patients.
Conclusions:
- Early diagnosis and treatment of viral infections in immunocompromised pediatric cancer patients can prevent fatal outcomes.
- Implementing prevention and control strategies is essential due to high transmission rates and viral shedding.
- Physicians need to be aware of treatment options despite the lack of randomized controlled trials in this specific group.
Abstract:
In severely immunocompromised patients, the diagnosis of viral infections relies on PCR/RT-PCR based methods. The availability of these modern diagnostic tools facilitates timely diagnosis and contributes to our increasing knowledge of the epidemiology and clinical spectrum of common and emerging viral pathogens in this highly susceptible population. Viral infections may result in life threatening disease in paediatric cancer patients after stem cell transplantation and also during conventional chemotherapy. Often, clinical symptoms are a consequence of endogenous reactivation of latent viral infection. Many of these viruses are easily transmitted between patients, relatives and health care workers. As prolonged symptomatic and asymptomatic viral shedding is a common feature in paediatric cancer patients, it is necessary to implement strategies for the prevention and control of these communicable pathogens in the hospital setting and in the outpatient clinic. Although no randomised controlled studies on paediatric cancer patients are available, physicians should be aware of potential treatment options since early treatment may prevent a complicated or fatal outcome and shorten the period of contagiosity.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:03Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:51Mechanisms of Retrovirus-induced Cancers